These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 23029375)
1. Conditional mesenchymal disruption of pkd1 results in osteopenia and polycystic kidney disease. Qiu N; Xiao Z; Cao L; David V; Quarles LD PLoS One; 2012; 7(9):e46038. PubMed ID: 23029375 [TBL] [Abstract][Full Text] [Related]
2. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation. Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454 [TBL] [Abstract][Full Text] [Related]
3. Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity. Xiao Z; Cao L; Liang Y; Huang J; Stern AR; Dallas M; Johnson M; Quarles LD PLoS One; 2014; 9(12):e114198. PubMed ID: 25464512 [TBL] [Abstract][Full Text] [Related]
4. Disruption of Kif3a in osteoblasts results in defective bone formation and osteopenia. Qiu N; Xiao Z; Cao L; Buechel MM; David V; Roan E; Quarles LD J Cell Sci; 2012 Apr; 125(Pt 8):1945-57. PubMed ID: 22357948 [TBL] [Abstract][Full Text] [Related]
5. Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis. Qiu N; Cao L; David V; Quarles LD; Xiao Z PLoS One; 2010 Dec; 5(12):e15240. PubMed ID: 21151991 [TBL] [Abstract][Full Text] [Related]
6. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. Xiao Z; Dallas M; Qiu N; Nicolella D; Cao L; Johnson M; Bonewald L; Quarles LD FASEB J; 2011 Jul; 25(7):2418-32. PubMed ID: 21454365 [TBL] [Abstract][Full Text] [Related]
7. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Baek WY; de Crombrugghe B; Kim JE Bone; 2010 Apr; 46(4):920-8. PubMed ID: 20026264 [TBL] [Abstract][Full Text] [Related]
8. Osteoblast lineage-specific effects of notch activation in the skeleton. Canalis E; Parker K; Feng JQ; Zanotti S Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471 [TBL] [Abstract][Full Text] [Related]
9. The effect of conditional inactivation of beta 1 integrins using twist 2 Cre, Osterix Cre and osteocalcin Cre lines on skeletal phenotype. Shekaran A; Shoemaker JT; Kavanaugh TE; Lin AS; LaPlaca MC; Fan Y; Guldberg RE; GarcĂa AJ Bone; 2014 Nov; 68():131-41. PubMed ID: 25183373 [TBL] [Abstract][Full Text] [Related]
10. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063 [TBL] [Abstract][Full Text] [Related]
11. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD. Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569 [TBL] [Abstract][Full Text] [Related]
12. Loss of osteoblast Runx3 produces severe congenital osteopenia. Bauer O; Sharir A; Kimura A; Hantisteanu S; Takeda S; Groner Y Mol Cell Biol; 2015 Apr; 35(7):1097-109. PubMed ID: 25605327 [TBL] [Abstract][Full Text] [Related]
13. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1. Starremans PG; Li X; Finnerty PE; Guo L; Takakura A; Neilson EG; Zhou J Kidney Int; 2008 Jun; 73(12):1394-405. PubMed ID: 18385665 [TBL] [Abstract][Full Text] [Related]
14. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II. Xiao Z; Zhang S; Magenheimer BS; Luo J; Quarles LD J Biol Chem; 2008 May; 283(18):12624-34. PubMed ID: 18321855 [TBL] [Abstract][Full Text] [Related]
15. An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. Takarada T; Hinoi E; Nakazato R; Ochi H; Xu C; Tsuchikane A; Takeda S; Karsenty G; Abe T; Kiyonari H; Yoneda Y J Bone Miner Res; 2013 Oct; 28(10):2064-9. PubMed ID: 23553905 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus. Stayner C; Shields J; Slobbe L; Shillingford JM; Weimbs T; Eccles MR Nephrology (Carlton); 2012 Nov; 17(8):739-47. PubMed ID: 22725947 [TBL] [Abstract][Full Text] [Related]
17. Large deletion of Wdr19 in developing renal tubules disrupts primary ciliogenesis, leading to polycystic kidney disease in mice. Yu SS; Wang E; Chiang CY; Cheng PH; Yeh YS; Wu YY; Chiou YY; Jiang ST J Pathol; 2022 May; 257(1):5-16. PubMed ID: 35007346 [TBL] [Abstract][Full Text] [Related]
19. Genetic interactions between polycystin-1 and Wwtr1 in osteoblasts define a novel mechanosensing mechanism regulating bone formation in mice. Xiao Z; Cao L; Smith MD; Li H; Li W; Smith JC; Quarles LD Bone Res; 2023 Oct; 11(1):57. PubMed ID: 37884491 [TBL] [Abstract][Full Text] [Related]
20. A new Cre driver mouse line, Tcf21/Pod1-Cre, targets metanephric mesenchyme. Maezawa Y; Binnie M; Li C; Thorner P; Hui CC; Alman B; Taketo MM; Quaggin SE PLoS One; 2012; 7(7):e40547. PubMed ID: 22792366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]